Winarto Hariyono, Laihad Bismarck Joel, Nuranna Laila
Division of Gynecology Oncology, Department of Obstetrics Gynecology, Faculty of Medicine, University of Indonesia, Jakarta, Indonesia E-mail :
Asian Pac J Cancer Prev. 2014;15(5):1949-53. doi: 10.7314/apjcp.2014.15.5.1949.
CA125 and HE4 are used in calculating Risk of Malignancy Algorithm (ROMA); and Risk of Malignancy Index (RMI). However, studies showed that normal levels of CA125, and HE4 differ among ethnicities such as between Asians and Caucasians, thus affecting the accuracy of the RMI score and ROMA in predicting ovarian malignancy. This study aimed to determine whether new or modified cutoff values for Ca- 125, HE4, the RMI score, and ROMA resulted in a better prediction of malignancy compared with the previous or standard ones.
Serum level of CA125 and HE4 from 128 patients with diagnosis of ovarian tumor that had been collected before surgery at Cipto Mangunkusumo General Hospital (CMH) in Jakarta from November 2010 until May 2011 were reviewed and analysed. The standard cutoff values of these biomarkers, RMI, and ROMA were modified by using logistic regression model. The modified cutoff values were compared to the standard cutoff values in terms of sensitivity, specificity, and accuracy.
The modified cutoff value of CA125, HE4, RMI score and ROMA were 165.2 U/mL, 103.4 pM, 368.7, 28/54. The sensitivity and specificity of the modified cutoff values CA125, HE 4, RMI score and ROMA in differentiating benign from malignant and borderline were 67% and 75,4%; 73.1% and 85.2%; 73.1% and 80.3%; and 77.6% and 86.9%. While the sensitivity and specificity of the standard cutoff value of CA125; HE4; RMI score; and ROMA were 91% and 24.6%; 83.6% and 65%; 80.6% and 65.6%; and 91.0% and 42.6%. The accuracy of modified cutoff values compared with standard cutoff values were: 71.2% vs 59.3%, 78.9% vs 75% vs, 76.5% vs 73.4%, and 82% vs 67.9%.
The new or modified cutoff values of Ca125, HE4, RMI score and ROMA resulted in higher accuracy compared to the previous or standard ones, at the cost of reduced sensitivity.
CA125和HE4用于计算恶性肿瘤风险算法(ROMA)以及恶性肿瘤风险指数(RMI)。然而,研究表明,CA125和HE4的正常水平在不同种族间存在差异,如亚洲人和白种人之间,这影响了RMI评分和ROMA在预测卵巢恶性肿瘤方面的准确性。本研究旨在确定与先前或标准的临界值相比,CA125、HE4、RMI评分和ROMA的新临界值或修改后的临界值是否能更好地预测恶性肿瘤。
回顾并分析了2010年11月至2011年5月在雅加达西托·芒古库苏莫综合医院(CMH)手术前收集的128例诊断为卵巢肿瘤患者的血清CA125和HE4水平。使用逻辑回归模型修改这些生物标志物、RMI和ROMA的标准临界值。将修改后的临界值与标准临界值在敏感性、特异性和准确性方面进行比较。
CA125、HE4、RMI评分和ROMA的修改后临界值分别为165.2 U/mL、103.4 pM、368.7、28/54。修改后的CA125、HE4、RMI评分和ROMA临界值在区分良性与恶性及交界性肿瘤方面的敏感性和特异性分别为67%和75.4%;73.1%和85.2%;73.1%和80.3%;77.6%和86.9%。而CA125、HE4、RMI评分和ROMA标准临界值的敏感性和特异性分别为91%和24.6%;83.6%和65%;80.6%和65.6%;91.0%和42.6%。与标准临界值相比,修改后临界值的准确性分别为:71.2%对59.3%、78.9%对75%、76.5%对73.4%、82%对67.9%。
与先前或标准临界值相比,CA125、HE4、RMI评分和ROMA的新临界值或修改后临界值准确性更高,但敏感性有所降低。